Determination of oxidative stress markers and their importance in early diagnosis of uremia-related complications

Indian Journal of Nephrology

Volumn 19, Issue 1, 2009, Pages 8-12

  Kolagal, V ^a   Karanam, S A ^a   Dharmavarapu, P K ^a   Dsouza, R ^a   Upadhya, S ^a   Kumar, V ^a   Kedage, V ^a   Muttigi, M S ^a   Shetty, J K ^a   Prakash, M ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Cardiovascular diseases; Ceruloplasmin; Copper; Glutathione S transferase; Malonyldialdehyde; Uremia

Indexed keywords

ALBUMIN; CERULOPLASMIN; COPPER; CREATININE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; PROTEIN; THIOL; UREA;

ADULT; ARTICLE; CERULOPLASMIN BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; COPPER BLOOD LEVEL; CREATININE BLOOD LEVEL; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; UREA BLOOD LEVEL; UREMIA;

EID: 77953435057     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.50673     Document Type: Article

References (40)

1. Ichikawa I, Kiyama S, Yoshioka T. Renal antioxidant enzymes: Their regulation and function. Kidney Int 1994;45:1-9.
2. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zing raff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-13.
3. Galle J. Oxidative stress in chronic renal failure. Nephrol Dial Transplant 2001;49:2135-7.
4. Dursun E, Ozben T, Suleymanlar G, Dursun B, Yakupoglu G. Effect of hemodialysis on the oxidative stress and antioxidants. Clin Chem Lab Med 2002;40:1009-13.
5. Gwozdzinski K. Red blood cell damage in chronic renal failure. Cell Mole Bio Lett 2005;7:191.
6. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: An emerging threat to patient outcome. Nephrol Dial Transplant 2003; 18:1272-80.
7. Luke RG. Chronic renal failure: A vasculopathic state. N Engl J Med 1998;339:841-3.
8. Locatelli F, Marcelli D, Conte F, D'Amico M, Del Vecchio L, Limido A, et al. Cardiovascular disease in chronic renal failure: The challenge continues. Nephrol Dial Transplant 2000; 15:S69-80.
9. Gonzalez BD. Progression of chronic renal failure and oxidative stress. Electron J Biomed 2003;1:5-11.
10. Walls J. Relationship between proteinuria and progressive renal disease. Am J Kidney Dis 2001;37:S13-6.
11. Descamps-Latscha B, Drueke T, Witko-Sarsat V. Dialysis induced oxidative stress: Biological aspects, clinical consequences and therapy. Semin Dial 2001; 14:193-9.
12. Klahr S. Oxygen radicals and renal diseases. Miner Electrolyte Metab 1997;23:140-3.
13. Pryor WA. Oxy-radicals and related species: Their formation, lifetimes and reactions. Annu Rev Physiol 1986;48:657-67.
14. Himmelfarb J, McMongale E, McManamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 2000;58:2571-8.
15. Himmelfarb J, McMongale E. Albumin is the major plasma protein thiol target of oxidant stress in uremia. Kidney Int 2001;60:358-63.
16. Osaki S, Johnson DA, Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem 1966;241:2746-51.
17. Cunningham J, Leffell M, Mearkle P, Harmatz P. Elevated plasma ceruloplasmin in insulin-dependent diabetes mellitus: Evidence for increased oxidative stress as a variable complication. Metabolism 1995;44:996-9.
18. Strain JJ. Newer aspects of micronutrients in chronic disease: Copper. Proc Nutr Soc 1994;53:583-98.
19. Yalin S, Hatungil R, Tamer L, Ates NA, Dogruer N, Yildirim H, et al. Glutathione S - transferase gene polymorphisms in Turkish patients with diabetes mellitus. Cell biochem funct 2007;25:509-13.
20. Klemm A, Voigt C, Friedrich M, Fünfstuck R, Sperschneider H, Jäger EG, et al. Determination of erythrocyte antioxidant capacity in haemodialysis patients using electron paramagnetic resonance. Nephrol Dial Transplant 2001; 16:2166-71.
21. Loguercio C, de Girolamo V, Cuomo A, Argenzio F, lannotta C, Disalvo D, et al. Determination of plasma alpha-transferases in chronic alcohol abusers: Relationship with alcohol intake and liver involvement. Alcohol Alcohol 1998;33:366-72.
22. Branten AJ, Mulder TP, Peters WH, Assmann KJ, Wetzels JF. Urinary excretion of isoenzymes of glutathione S-transferase alpha and pi in patients with proteinuria: Reflection of the site of tubular injury. Nephron 2000;85:120-6.
23. Motchnik AP, Frei, Ames NB. Measurement of antioxidants in human plasma: Protein thiols. In: Oxygen radicals in biological systems: Methods in enzymology, part D, California: Academic Press; 1994. p. 234, 273-4.
24. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-tranferases: The first enzymatic step in mercapturic acid formation. J Biol Chem 1974:249:7130-9.
25. Harvey JW, Beutler E. Binding of heme by glutathiones S-transferases: A possible role of erythrocyte enzyme. Blood 1982;60:1227-30.
26. Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff SP. Elevated levels of authentic plasma hydroperoxides in non insulin dependent diabetes mellitus. Diabetes 1995;44:1054-8.
27. Ravin HA. An improved colorimetric enzymatic assay of Ceruloplasmin. J Lab Clin Med 1961;58:161-8.
28. Prakash M, Shetty JK. A modified spectrophotometric micromethod to determine serum copper. Asian J Biochem 2008;3:38-42.
29. Prakash M, Shetty JK, Rao L, Sharma S, Rodrigues A, Prabhu R. Serum paraoxonase activity and protein thiols in cronic renal failure patients. Indian J Nephrol 2008; 18:13-6.
30. Prakash M, Upadhya S, Prabhu R. Protein thiol oxidation and lipid peroxidation in patients with uremia. Scand J Clin Lab Invest 2004;64:599-604.
31. Descamps-Latscha B, Witko-Sarsat V. Oxidative stress in chronic renal failure and hemodialysis. Nephrologie 2003;24:377-9.
32. Yang XB, Hou FF, Wu Q, Zhou H, Liu ZR, Yang Y, et al. Increased levels of advanced oxidation protein products are associated with kidney disease. Zhonghua Nei Ke Za Zhi 2005;44:342-6.
33. Wada T, Miyata T, Kurokawa K. Implications of carbonyl stress in long term uraemic complications. Nephrol Dial Transplant 1999;14:79-81.
34. Odani H, Shinzato T, Matsumoto Y, Usami J, Maeda K. Increase in three alpha, beta-dicarbonyl compound levels in human uremic plasma: Specific in vivo determination of intermediates in advanced Maillard reaction. Biochem Biophys Res Commun 1999;256:89-93.
35. Agalou S, Karachalias N, Tucker B, Thornalley PJ, Dawnay A. Estimation of alpha-oxoaldehydes formed from the degradation of glycolytic intermediates and glucose fragmentation in blood plasma of human subjects with uraemia. Int Congr Ser 2002; 1245:182.
36. Shukla N, Maher J, Masters J, Angelini GD, Jeremy JY. Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor? Atherosclerosis 2006; 187:238-50.
37. Letelier ME, Lepe AM, Faúndez M, Salazar J, Mańn R, Aracena P, et al. Possible mechanisms underlying copper-induced damage in biological membranes leading to cellular toxicity. Chem Biol Interact 2005;151:71-82.
38. Lynch SM, Frei B. Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein. Biochim Biophys Acta 1997;1345:215-21.
39. Craig WY, Poulin SE, Palomaki GE, Neveux LM, Ritchie RF, Ledue TB. Oxidation-related analytes and lipid and lipoprotein concentrations in healthy subjects. Arterioscler Thromb Vase Biol 1995; 15:733-9.
40. Galli F, Rovdati S, Benedetti S, Buoncristiani LJ, Covarelli C, Floridi A, et al. Overexpression of erythrocyte glutathione S - transferase in uremia and dialysis. Clin Chem 1999;45:1781-8.